Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Total Current Liabilities: 2024-2025

Historic Total Current Liabilities for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $19.4 million.

  • Pyxis Oncology's Total Current Liabilities fell 4.62% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year decrease of 4.62%. This contributed to the annual value of $17.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Total Current Liabilities is $19.4 million, which was up 9.64% from $17.7 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Total Current Liabilities peaked at $20.3 million during Q3 2024, and registered a low of $14.1 million during Q1 2024.
  • For the 2-year period, Pyxis Oncology's Total Current Liabilities averaged around $17.2 million, with its median value being $17.7 million (2025).
  • Over the last 5 years, Pyxis Oncology's Total Current Liabilities had its largest YoY gain of 4.62% in 2025, and its largest YoY loss of 4.62% in 2025.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Total Current Liabilities stood at $17.7 million in 2024, then dropped by 4.62% to $19.4 million in 2025.
  • Its last three reported values are $19.4 million in Q3 2025, $17.7 million for Q2 2025, and $14.4 million during Q1 2025.